Significant Ownership of CITADEL ADVISORS LLC

Notable people
Ken Griffin
Signature - Title
/s/ Seth Levy - Seth Levy, Authorized Signatory
Location
Miami, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by CITADEL ADVISORS LLC.

Notify me when CITADEL ADVISORS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of CITADEL ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ASST Strive, Inc. Class A Common Stock, $0.001 par value per share (the "Shares") 10% $103,617,158 41,446,863 Kenneth Griffin 30 Sep 2025
AREC American Resources Corporation Class A common stock, par value $0.0001 per share (the "Shares") 10% $26,637,887 9,865,884 Kenneth Griffin 14 Oct 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") 10% $1,359,648 109,649 Citadel Advisors LLC 09 Oct 2025
MEIP MEI Pharma, Inc. Common Stock, par value $0.00000002 per share (the "Shares") 10% 3,245,888 Kenneth Griffin 22 Jul 2025
FLYY Spirit Aviation Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 9.9% 1,624,877 Kenneth Griffin 29 Apr 2025
LXEO Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") 9.6% $25,177,009 5,334,112 Kenneth Griffin 30 Jun 2025
NB NioCorp Developments Ltd. Common Shares, without par value (the "Shares") 8.2% $53,114,357 +$27,039,678 7,951,251 +104% Kenneth Griffin 30 Sep 2025
ASST ASSET ENTITIES INC. Class B Common Stock, par value $0.0001 per share (the "Shares") 8.1% $8,485,777 1,268,427 Kenneth Griffin 18 Aug 2025
SPAI Safe Pro Group Inc. Common Stock, par value $0.0001 per share (the "Shares") 6.7% $9,205,480 -$1,336,545 1,311,322 -13% Kenneth Griffin 30 Sep 2025
FGF FG Nexus Inc. Common Stock, par value $0.001 per share (the "Shares") 6.6% $42,399,476 2,501,444 Kenneth Griffin 05 Sep 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 6.4% $65,002,336 9,194,107 Kenneth Griffin 07 Apr 2025
BOLD Boundless Bio, Inc. Common stock, par value $0.0001 per share (the "Shares") 6.4% $1,763,067 1,433,388 Kenneth Griffin 26 Nov 2025
NA Nano Labs Ltd Class A ordinary shares, par value US$0.002 per share (the "Shares") 6.2% $7,347,089 -$3,916,226 1,360,572 -35% Kenneth Griffin 30 Sep 2025
SNCY Sun Country Airlines Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 6.1% $33,215,936 3,196,914 Kenneth Griffin 11 Feb 2025
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 6.1% $15,081,151 13,346,151 Kenneth Griffin 09 Jul 2025
JUPGD Atlas Critical Minerals Corporation Common stock, par value $0.001 per share (the "Shares") 6% $3,883,745 298,520 Kenneth Griffin 12 Jan 2026
ATLX Atlas Lithium Corporation Common Stock, par value $0.001 per share (the "Shares") 5.9% $7,929,614 1,557,881 Kenneth Griffin 08 Dec 2025
INSP Inspire Medical Systems, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.8% $127,107,716 1,713,042 Kenneth Griffin 29 Sep 2025
AARD Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 5.6% $8,517,813 1,192,971 Kenneth Griffin 14 Feb 2025
RZLV Rezolve AI plc Ordinary Shares, par value (GBP)0.0001 per share (the "Shares") 5.5% $106,353,345 15,663,232 Kenneth Griffin 25 Sep 2025
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.5% $3,116,579 +$326,709 1,721,867 +12% Kenneth Griffin 14 Nov 2025
HOND HCM II Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (the "Shares") 5.4% $14,310,259 1,233,643 Kenneth Griffin 23 Sep 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.3% $12,406,187 980,610 Kenneth Griffin 04 Nov 2025
QUBT Quantum Computing Inc. Common stock, par value $0.0001 per share (the "Shares") 4.9% $146,902,081 9,244,939 Kenneth Griffin 25 Sep 2025
PLRX PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") 4.9% $3,650,136 2,991,915 Kenneth Griffin 14 Jan 2026
TARA Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 4.7% $6,348,163 1,627,734 Kenneth Griffin 31 Dec 2024
DFDV DeFi Development Corp. Common Stock, par value $0.00001 per share (the "Shares") 4.5% $19,964,392 1,315,654 Kenneth Griffin 14 Oct 2025
SLRN ACELYRIN, Inc. Common Stock, par value $0.00001 per share (the "Shares") 4.2% $9,407,808 4,218,748 Kenneth Griffin 31 Dec 2024
OPAD Offerpad Solutions Inc. Class A common stock, $0.0001 par value per share (the "Shares") 4.2% $2,346,543 1,971,885 Kenneth Griffin 13 Jan 2026
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") 4.1% $7,970,206 3,465,307 Kenneth Griffin 31 Dec 2024
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share (the "Shares") 4.1% $6,003,741 2,900,358 Kenneth Griffin 30 Sep 2025
SPHR Sphere Entertainment Co. Class A Common Stock 3.9% $29,008,329 1,115,276 Kenneth Griffin 31 Mar 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.9% $5,316,761 369,733 Citadel Advisors LLC 31 Dec 2024
ALHC Alignment Healthcare, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.4% $117,229,222 -$66,136,407 6,718,007 -36% Kenneth Griffin 30 Sep 2025
CGEM Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") 3.4% $11,794,219 -$6,049,899 1,988,907 -34% Kenneth Griffin 30 Sep 2025
CABA Cabaletta Bio, Inc. Common stock, par value $0.00001 per share (the "Shares") 3.4% $7,371,644 -$3,903,787 3,150,275 -35% Kenneth Griffin 30 Sep 2025
DGXX DIGI POWER X INC. Subordinate Voting Shares, with no par value per share (the "Shares") 3.4% $3,474,120 1,517,083 Kenneth Griffin 10 Oct 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Class A ordinary share, par value $0.0001 per share (the "Shares") 3.2% $29,112,489 2,538,142 Kenneth Griffin 30 Sep 2025
UWMC UWM Holdings Corporation Class A Common Stock, par value $0.0001 per share (the "Shares") 2.8% $31,776,533 -$43,587,881 5,584,628 -58% Kenneth Griffin 30 Jun 2025
BKKT Bakkt Holdings, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 2.7% $14,332,982 -$30,063,482 425,943 -68% Kenneth Griffin 30 Sep 2025
FVR FrontView REIT, Inc. Common Stock, $0.01 par value 2.4% $4,918,822 408,540 Kenneth Griffin 31 Mar 2025
ADT ADT Inc. Common stock, par value $0.01 per share (the "Shares") 2.2% $151,592,528 -$229,419,344 17,464,577 -60% Kenneth Griffin 30 Jun 2025
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 2% $1,325,025 1,409,601 Kenneth Griffin 31 Mar 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value of GBP 0.008 per share (the "Shares"), each represented by one American Depositary Share 1.7% $3,324,742 1,166,576 Kenneth Griffin 31 Dec 2024
ARVN ARVINAS, INC. Common stock, par value $0.001 per share (the "Shares") 0.4% $2,251,350 -$27,399,315 264,243 -92% Kenneth Griffin 30 Sep 2025
ALTS ALT5 Sigma Corporation Common Stock, par value $0.001 per share (the "Shares") 0.2% $2,359,768 282,607 Kenneth Griffin 12 Aug 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 (the "Shares") 0% $1,238 -$363,632 3,732 -100% Kenneth Griffin 30 Sep 2025
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024
CBNA Chain Bridge Bancorp, Inc. Class A common stock, par value $0.01 per share 0% $0 0 Citadel Advisors LLC 31 Mar 2025
HE HAWAIIAN ELECTRIC INDUSTRIES INC Common Stock, Without Par Value (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024

Schedules 13D/G Reported by CITADEL ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.